The-treatment | Biotechnology News

Posts Tagged ‘the-treatment’

BioVex starts phase-I trial of genital herpes vaccine ImmunoVEXHSV2 (PharmaBiz)

8 Mar 2010

BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced that the first subject had been dosed in the phase-1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2.

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience (News-Medical-Net)

In: Biotechnology News

8 Feb 2010

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.

No Comments
Tags: a-leading-global, and-marketing, and-risk, apcer, china-based, develop-and, leading-global, management-programs, medical-device, panacor, the-treatment, today-announced, treatment

Entries (RSS)
Comments (RSS)

About Biolexis

Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.